Abstraction Health

Resveratrol — Research Evidence

Source: PubMed / NCBI · human studies preferred · ranked by evidence qualityLast analyzed: May 24, 2026
Insufficient Evidence
20 studies·5 RCTs·13 reviews

The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.

The available research on resveratrol spans multiple health domains — including metabolic health, bone density, cardiovascular function, liver disease, and aging — but the overall evidence base is fragmented and largely insufficient to draw firm conclusions. The 15 studies provided include a mix of narrative reviews, a small number of RCTs, and two meta-analyses, covering diverse populations and outcomes without a consistent focus. While resveratrol is a well-characterized polyphenol found naturally in grapes, red wine, blueberries, and peanuts, translating its promising preclinical profile into demonstrated human benefits has proven difficult. Of 13 expert claims evaluated, 12 were rated as having insufficient evidence, and only one — describing resveratrol's natural food sources — was even partially supported.

Key findings

  • Resveratrol is a naturally occurring polyphenol present in red wine, grapes, blueberries, and peanuts — this basic biochemical fact is well established.
  • A small number of RCTs suggest possible benefits for bone mineral density in postmenopausal women and for metabolic markers in type 2 diabetes, but these trials are individually of moderate quality and limited in size.
  • Meta-analytic evidence for polyphenol supplementation in non-alcoholic fatty liver disease is rated strong in quality, but resveratrol's specific contribution within that class of compounds remains unclear.
  • Reviews touching on cardiovascular, anti-aging, and neuroprotective effects of resveratrol reflect largely preclinical or theoretical frameworks, with human clinical data remaining sparse.
  • Resveratrol has been flagged in reviews as a potential interactor with direct oral anticoagulants, raising a clinically relevant drug-food interaction concern.

Evidence gaps

  • ?Nearly all outcome areas — including cognitive health, endometriosis, preeclampsia prevention, and cancer chemoprevention — lack dedicated, high-quality human RCTs specifically testing resveratrol, leaving major uncertainty about real-world efficacy.
  • ?Optimal dosing, duration, and bioavailability of resveratrol in humans are not well defined by the available studies, making it difficult to translate any positive findings into practical supplementation guidance.
  • ?Long-term safety data in diverse human populations is absent from the current evidence base; most safety observations come from short-duration trials or descriptive reviews rather than controlled long-term studies.

Safety summary

Short-term resveratrol supplementation appears generally well tolerated in the RCTs reviewed, but potential interactions with anticoagulant medications have been noted in review literature. Long-term safety has not been adequately studied in human populations.

Studies (20)

Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis.

Postgraduate medical journal · 2022 · Chan V et al.
Meta-Analysis🟢
Key finding

Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis.

COI: Competing interests: None declared.
PMID: 33441476DOI: 10.1136/postgradmedj-2020-139319
View on PubMed

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Frontiers in immunology · 2022 · Yang K et al.
Meta-Analysis🟢
Key finding

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.

COI: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
PMID: 36159792DOI: 10.3389/fimmu.2022.949746
View on PubMed

Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.

Nutrients · 2022 · Inchingolo AD et al.
Systematic Review🟢
Key finding

Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.

Funded by: European Social Found, Human Capital Operational Programme 2014-2020
COI: The authors declare no conflict of interest.
PMID: 36079777DOI: 10.3390/nu14173519
View on PubMed

Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.

Cell metabolism · 2011 · Timmers S et al.
RCT🟡
Key finding

Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.

Funded by: European Research Council
PMID: 22055504DOI: 10.1016/j.cmet.2011.10.002
View on PubMed

Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.

Nutrients · 2024 · Erol Doğan Ö et al.
RCT🟡
Key finding

Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.

COI: The authors declare no conflicts of interest.
PMID: 38794742DOI: 10.3390/nu16101504
View on PubMed

Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.

Complementary therapies in medicine · 2022 · Mahjabeen W et al.
RCT🟡
Key finding

Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.

PMID: 35240291DOI: 10.1016/j.ctim.2022.102819
View on PubMed

Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020 · Wong RH et al.
RCT🟡
Key finding

Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.

Funded by: Industry (inferred from affiliations)
PMID: 32564438DOI: 10.1002/jbmr.4115
View on PubMed

Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.

International journal of molecular sciences · 2023 · Corbi G et al.
RCT🟡
Key finding

Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.

Funded by: Industry (inferred from affiliations)
COI: The authors declare no conflict of interest.
PMID: 37569440DOI: 10.3390/ijms241512063
View on PubMed

Dietary supplements and prevention of preeclampsia.

Hypertension research : official journal of the Japanese Society of Hypertension · 2025 · Ushida T et al.
Review🟡
Key finding

Dietary supplements and prevention of preeclampsia.

COI: Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.
PMID: 39930022DOI: 10.1038/s41440-025-02144-9
View on PubMed

Hormesis determines lifespan.

Ageing research reviews · 2024 · Calabrese EJ et al.
Review🟡
Key finding

Hormesis determines lifespan.

Funded by: Industry (inferred from affiliations)
COI: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PMID: 38182079DOI: 10.1016/j.arr.2023.102181
View on PubMed

Resveratrol and Its Effects on the Vascular System.

International journal of molecular sciences · 2019 · Breuss JM et al.
Review🟡
Key finding

Resveratrol and Its Effects on the Vascular System.

Funded by: Austrian Science Fund FWF
COI: The authors declare no conflict of interest.
PMID: 30934670DOI: 10.3390/ijms20071523
View on PubMed

Resveratrol and cancer: focus on in vivo evidence.

Endocrine-related cancer · 2014 · Carter LG et al.
Review🟡
Key finding

Resveratrol and cancer: focus on in vivo evidence.

Funded by: NIDDK NIH HHS, NCI NIH HHS, NIGMS NIH HHS, NCRR NIH HHS
PMID: 24500760DOI: 10.1530/ERC-13-0171
View on PubMed

Dietary supplements for treatment of endometriosis: A review.

Acta bio-medica : Atenei Parmensis · 2022 · Yalçın Bahat P et al.
Review🟡
Key finding

Dietary supplements for treatment of endometriosis: A review.

COI: Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
PMID: 35315418DOI: 10.23750/abm.v93i1.11237
View on PubMed

The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants.

International journal of molecular sciences · 2021 · Grześk G et al.
Review🟡
Key finding

The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants.

Funded by: Uniwersytet Mikolaja Kopernika w Toruniu
COI: G.G. received honoraria from Bayer, Boehringer Ingelheim and Pfizer for lectures. D.R. received honoraria from Bayer and AstraZeneca for lectures. Ł.W. received honoraria from Bayer for lectures. The remaining authors declare no conflict of interest.
PMID: 34445237DOI: 10.3390/ijms22168531
View on PubMed

Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.

Nutrients · 2025 · Gualtieri P et al.
Review🟡
Key finding

Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.

Funded by: Ministero della Salute
COI: The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.
PMID: 40077790DOI: 10.3390/nu17050922
View on PubMed

Resveratrol (RV): A pharmacological review and call for further research.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021 · Zhang LX et al.
Review🟡
Key finding

Resveratrol (RV): A pharmacological review and call for further research.

Funded by: Industry (inferred from affiliations)
PMID: 34649335DOI: 10.1016/j.biopha.2021.112164
View on PubMed

A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions.

CNS & neurological disorders drug targets · 2023 · Majhi S et al.
Review🟡
Key finding

A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions.

Funded by: Industry (inferred from affiliations)
PMID: 36915952DOI: 10.2174/1871527321666220428134802
View on PubMed

Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis: from the Mediterranean Diet To the Ketogenic Diet, Through Supplementation. The Role of the Nutritionist in Clinical Management.

Current obesity reports · 2025 · Barrea L et al.
Review🟡
Key finding

Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis: from the Mediterranean Diet To the Ketogenic Diet, Through Supplementation. The Role of the Nutritionist in Clinical Management.

COI: Declarations. Competing interests: The authors declare no competing interests.
PMID: 40920291DOI: 10.1007/s13679-025-00662-8
View on PubMed

Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.

British journal of pharmacology · 2017 · Shen CY et al.
Review🟡
Key finding

Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.

PMID: 27659301DOI: 10.1111/bph.13631
View on PubMed

Resveratrol and chemoprevention.

Cancer letters · 2009 · Goswami SK et al.
Review🟡
Key finding

Resveratrol and chemoprevention.

PMID: 19261378DOI: 10.1016/j.canlet.2009.01.041
View on PubMed